Efficacy of Probiotics Supplementation On Chronic Kidney Disease: a Systematic Review and Meta-Analysis

被引:56
|
作者
Jia, Linpei [1 ]
Jia, Qiang [1 ]
Yang, Jingyan [2 ]
Jia, Rufu [2 ]
Zhang, Hongliang [3 ]
机构
[1] Capital Med Univ, Dept Nephrol, Xuanwu Hosp, Beijing, Peoples R China
[2] Cent Hosp Cangzhou, Cangzhou, Peoples R China
[3] Natl Nat Sci Fdn China, Dept Life Sci, Beijing, Peoples R China
来源
KIDNEY & BLOOD PRESSURE RESEARCH | 2018年 / 43卷 / 05期
关键词
Probiotics; Chronic kidney disease; Uremic toxin; Intestinal microbiota; Randomized controlled trial; P-CRESOL; CARDIOVASCULAR RISK; SYNBIOTIC TREATMENT; GUT MICROBIOTA; RENAL-FAILURE; DOUBLE-BLIND; JAK-STAT; HEALTHY; MICROFLORA; CYTOKINE;
D O I
10.1159/000494677
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background/Aims: Dysbiosis of the intestinal microbiota may accelerate the progression of chronic kidney disease (CKD) by increasing the levels of urea toxins. In recent years, probiotics have been recognized to maintain the physiological balance of the intestinal microbiota. In this study, we aim to assess the therapeutic effects of probiotics on CKD patients with and without dialysis via meta-analysis. Methods: We conducted a meta-analysis of randomized controlled trials (RCTs) by searching the databases of Pubmed, EMBASE and Cochrane Library (No. CRD42018093080). Studies on probiotics for treatment of CKD adults lasting for at least 4 weeks were selected. The primary outcomes were the levels of urea toxins, and the second outcomes were the levels of interleukin (IL)-6, C-reactive protein (CRP) and hemoglobin (Hb). The risk of bias was assessed by Cochrane Collaboration' tool, and the quality of evidence was appraised with the Grading of Recommendation Assessment. Means and standard deviations were analyzed by random effects analysis. Stratified analysis was done and sensitivity analysis was performed when appropriate. Results: Totally, eight studies with 261 patients at CKD stage 3 to 5 with and without dialysis were included. We found a decrease of p-cresyl sulfate (PCS) of 3 studies with 125 subjects (P = 0.01, SMD-0.57, 95% CI,-0.99 to-0.14, /2 = 25%) and an increase of IL-6 in 3 studies with 134 subjects (P = 0.03, 95% CI, SMD 0.37, 0.03 to 0.72, /2 = 0%) in the probiotics groups. Analysis of serum creatinine (P = 0.47), blood urine nitrogen (P = 0.73), CRP (P = 0.55) and Hb (P = 0.49) yielded insignificant difference. Conclusion: Limited number of studies and small sample size are limitations of our study. Probiotics supplementation may reduce the levels of PCS and elevate the levels of IL-6 whereby protecting the intestinal epithelial barrier of patients with CKD. (C) 2018 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:1623 / 1635
页数:13
相关论文
共 50 条
  • [21] Efficacy and Safety of Vadadustat for Anemia in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
    Xiong, Limei
    Zhang, Hui
    Guo, Yannan
    Song, Yue
    Tao, Yuhong
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [22] Efficacy of statins on renal function in patients with chronic kidney disease: a systematic review and meta-analysis
    Zhao, Lin
    Li, Shu
    Gao, Ying
    RENAL FAILURE, 2021, 43 (01) : 718 - 728
  • [23] The efficacy of tolvaptan for heart failure in chronic kidney disease: A protocol for systematic review and meta-analysis
    Zhu, Zhi-Yong
    Cui, Meng
    Zhao, Jie
    Wang, Hong-Yun
    MEDICINE, 2022, 101 (52) : E32366
  • [24] The Efficacy of Paricalcitol Administration for Management of Pediatric Chronic Kidney Disease: A Systematic Review and Meta-analysis
    Fazel, Mojtaba
    Khari, Sorour
    Gubari, Mohammed I. M.
    Ataei, Neamatollah
    Yousefifard, Mahmoud
    Hosseini, Mostafa
    INTERNATIONAL JOURNAL OF PEDIATRICS-MASHHAD, 2020, 8 (02): : 10951 - 10959
  • [25] Efficacy and Safety of Oral Anticoagulants in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
    Malhotra, Konrak
    Ishfaq, Muhammad F.
    Goyal, Nitin
    Parissis, John
    Alexandrov, Anne
    Alexandrov, Andrei
    Tsivgoulis, Georgios
    STROKE, 2019, 50
  • [26] A systematic review and meta-analysis on the efficacy of probiotics for bacterial vaginosis
    Liu, H-F
    Yi, N.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (01) : 90 - 98
  • [27] Efficacy of probiotics in the management of halitosis: a systematic review and meta-analysis
    Huang, Nengwen
    Li, Jinjin
    Qiao, Xianghe
    Wu, Yongzhi
    Liu, Yunkun
    Wu, Chenzhou
    Li, Longjiang
    BMJ OPEN, 2022, 12 (12): : e060753
  • [28] Effect of Probiotics Supplementation on Cortisol Levels: A Systematic Review and Meta-Analysis
    Jain, Manav
    Anand, Aishwarya
    Sharma, Nisha
    Shamim, Muhammad Aaqib
    Enioutina, Elena Y.
    NUTRIENTS, 2024, 16 (20)
  • [29] Efficacy of Vitamin C Supplementation on Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis
    Lei, Ting
    Lu, Tingting
    Yu, Haichuan
    Su, Xiaojie
    Zhang, Chuchu
    Zhu, Lei
    Yang, Kehu
    Liu, Jian
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 2201 - 2216
  • [30] Clinical efficacy of probiotics in the treatment of alcoholic liver disease: a systematic review and meta-analysis
    Xiong, Shi-Ying
    Wu, Gui-Sheng
    Li, Chun
    Ma, Wenzhe
    Luo, Huai-Rong
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14